Loading...
OTCM
ACAN
Market cap2kUSD
Jun 13, Last price  
0.00USD
1D
0.00%
1Q
-99.68%
Jan 2017
-100.00%
IPO
-100.00%
Name

Americann Inc

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.20%
Rev. gr., 5y
156.13%
Revenues
1m
-50.05%
000030,000140,00060,00040,000011,564503,5122,028,5512,927,8192,552,2001,274,810
Net income
-1m
L+1,223.76%
0002,500-1,301,374-1,729,344-2,210,764-2,771,894-4,432,716-5,461,229-1,565,813-1,788,384-829,215-94,755-1,254,329
CFO
-1m
L
0002,500-515,378-792,534-540,863-1,747,948-2,403,321-2,188,594518,333-275,153848,738579,860-1,170,066
Earnings
Aug 11, 2025

Profile

AmeriCann, Inc. operates as a specialized cannabis company in the United States. It designs, develops, leases, and operates cultivation, processing, and manufacturing facilities for licensed cannabis businesses. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is based in Denver, Colorado.
URL
https://americann.co/
IPO date
Sep 10, 2013
Employees
3
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
1,275
-50.05%
2,552
-12.83%
2,928
44.33%
Cost of revenue
2,020
1,941
2,445
Unusual Expense (Income)
NOPBT
(746)
612
483
NOPBT Margin
23.97%
16.49%
Operating Taxes
656
Tax Rate
135.89%
NOPAT
(746)
612
(173)
Net income
(1,254)
1,223.76%
(95)
-88.57%
(829)
-53.63%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
4,513
5,094
161
Long-term debt
8,396
8,421
13,364
Deferred revenue
Other long-term liabilities
Net debt
12,860
12,042
12,184
Cash flow
Cash from operating activities
(1,170)
580
849
CAPEX
(279)
(246)
Cash from investing activities
84
(636)
(204)
Cash from financing activities
(150)
FCF
146
837
70
Balance
Cash
49
1,135
1,341
Long term investments
338
Excess cash
1,345
1,195
Stockholders' equity
(21,105)
(19,851)
(19,756)
Invested Capital
34,263
34,857
34,856
ROIC
1.75%
ROCE
4.08%
3.20%
EV
Common stock shares outstanding
24,392
24,392
24,334
Price
0.03
-89.85%
0.33
17.44%
0.28
-64.88%
Market cap
817
-89.85%
8,049
17.72%
6,838
-64.19%
EV
13,677
20,091
19,022
EBITDA
(213)
1,137
1,001
EV/EBITDA
17.67
19.00
Interest
550
710
667
Interest/NOPBT
116.05%
138.27%